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Background: Comprehensive smoke-free legislation has been implemented in many countries. The current study
quantitatively examined the reduction in risk of acute myocardial infarction (MI) occurrence following the
legislations and the relationship with the corresponding smoking prevalence decrease.
Methods: PubMed, EMBASE, and Google Scholar databases and bibliographies of relevant studies and reviews were
searched for potential original studies published from January 1, 2004, through October 31, 2011. Meta-analysis was
performed using a random effect model to estimate the overall effects of the smoking-free legislations.
Meta-regression was used to investigate possible causes of heterogeneity in risk estimates.
Results: A total of 18 eligible studies with 44 estimates of effect size were used in this study. Meta-analysis produced a
pooled estimate of the relative risk of 0.87 (95% confidence interval (CI): 0.84 to 0.91). There was significant heterogeneity
in the risk estimates (overall I2 = 96.03%, p<0.001). In meta-regression analysis, studies with greater smoking prevalence
decrease produced larger relative risk (adjusted coefficient −0.027, 95% CI: -0.049 to −0.006, p=0.014).
Conclusion: Smoke-free legislations in public and work places were associated with significant reduction in acute MI
risk, which might be partly attributable to reduced smoking prevalence.
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Tobacco smoking is projected to kill about one billion
people worldwide in the 21st century [1]. The harmful ef-
fects of smoking are not only confined to active tobacco
consumers, but also for those exposed to environmental
tobacco smoke (ETS) [2], which is listed as the third lead-
ing cause of preventable poor health and premature deaths
in the developed world [3]. According to the US Surgeon
General’s report, tobacco smoking is a major population
risk factor for coronary heart disease, the leading cause of
deaths in the US [4]. Including acute myocardial infarction
(MI), coronary heart disease has remained the second
leading cause of deaths over the past three decades [4,5].
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reproduction in any medium, provided the ormany countries to enacted various smoking regulations in
order to directly decrease exposure to environmental to-
bacco smoke and indirectly reduce active smoking, in
hope to prevent and reduce smoking-related morbidity
and mortality such as acute MI [6,7]. These smoking bans
usually prohibited smoking activity in public and working
places, such as restaurants, workplaces, and bars, although
differnce existed among countries and cities [8]. A grow-
ing body of evidence has suggested that the rate of acute
myocardial infarction significantly decreased after the
introduction of the smoking ban regulations, usually
within a short time period. However, the results published
so far showed a large variation of the effect size, ranging
from 5% to 70% [9]. On the other hand, the relationship of
this reduction with the corresponding smoking prevalence
change remained unknown. This study performed a sys-
tematic literature review and meta-analysis with the aim
to estimate the overall effect size of smoke-free legislations
on the risk of acute MI in the general population, and to. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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prevalence and the acute MI rate change after the
smoking-free legislations.
Methods
The literature search was conducted to find potential stud-
ies published from January 1, 2004, through October 31,
2011. We used the MEDLINE, EMBASE, and Google
Scholar database without restrictions and we included arti-
cles that were ahead of publications. The following key-
words were used in the literature searching: “smoking ban”
and “heart” or ”myocardial infarct”. Moreover, we searched
for the keywords in headers and abstracts and also
performed a manual search of references cited in the se-
lected articles and published reviews to look for any add-
itional relevant studies. A total of 19 studies were identified,
of which, 18 had been published in peer-reviewed journals
and 1 had not. The latter study did not provide enough in-
formation for us to calculate relative risk and confidence
interval, was thus not included in the meta-analysis.
Two individual studies included the city of Pueblo,
Colorado: the first was on the effects for the first 18
months after the law being implemented [10] and the sec-
ond was after 36 months [11]. And two studies reported
that of the City of Graubuenden, Switzerland. One was
one year after the smoking ban and the other one was two
years after the regulation [12,13]. Data of Piedmont, Italy
were used as part of one study, which was for the effect of
2 months after the law went into effect [14] and another
study examined the effect of the smoking ban in Piedmont
after 6 months of the implementation [15]. These studies
were initially treated as independent observations in this
study, although there was some overlaps in the baseline
information. And in the sensitivity analysis, we only in-
cluded the more recent studies for these cities in order to
check the robustness of the result estimation. Information
of New York was also included in two studies: one includ-
ing the residents aged 35 years and over [16], the second
including those of 45 years and above [17], only the
former one was included in this analysis as it included the
information of the latter one. One study [14] reported re-
sults from four Italian regions, one of which had already
been reported individually [15]; the results for the other
three regions were used separately into the meta-analysis.
Some studies reported separate relative risks for differ-
ent age subgroups and sexes, these estimates were entered
separately into the meta-analysis. The meta-analysis was
therefore based on a total of 44 estimates of relative risk
obtained from 18 individual studies.
When population data were not provided in the stud-
ies, they were obtained from the relevant country's cen-
sus records. If the smoking prevalence information was
not available in the study, the information was extracted
from various sources. For example, the studies in theUSA, data were obtained from a report by American
Lung Association [18]. And information of Toronto,
Ontario Canada was obtained from [19], England from
[20], Italy from [21], Christchurch, New Zealand from
[22], Graubuenden, Switzerland from [23,24].
All analyses were performed using R software. As the
studies were conducted in different countries and circum-
stances, we utilized a random-effect meta-analysis which
allowed for non-random variability in effect estimates be-
tween the studies. A forest plot was produced to illustrate
the contributions of each individual study in terms of their
estimated effect size and the 95% confidence interval (CI).
To examine potential publication bias, we plotted the
standard errors (SEs) of the studies against the corre-
sponding effect sizes. We assessed the possibility of publi-
cation bias by visually measuring the asymmetry of the
funnel plot. A funnel plot could allow for widening 95%
CI lines with decreasing study size. If there was no signifi-
cant bias, 95% of the studies would lie within these lines
and, in the absence of small study bias, the plotted results
should be symmetrical. We also used the Egger's linear re-
gression method to statistically examine the symmetry.
Meta-regression analysis was further conducted to exam-
ine whether the estimate of relative risk (RR) was associ-
ated with such factors as population size, study location
(U.S. or non-U.S.), publication year and smoking preva-
lence decrease.
Results
This systematic review identified 18 eligible studies (9
conducted in US, 3 in Italy, 2 in Canada, 2 in Switzerland,
1 in Great Britain and 1 in New Zealand). All of the stud-
ies were based on acute MI hospitalization except that
three studies used acute MI mortality data [17,25,26].
All of the studies included a pre- and post- comparison
of the acute MI hospitalization or mortality rate. Eleven
also included a geographical comparison area where legis-
lation had not yet been implemented [3,7,11,13,17,25-29].
These studies were all ecologic in the study design, and
they varied widely in population size (ranging from 9,100
to more than 15 million), and in the duration of post-ban
observation (from 2 to 36 months, with only 3 studies
reporting results of within 12 months [14,15,28]).
As shown in Figure 1, the overall relative risk of acute
MI before and after smoking-free legislations was 0.87
(95% CI: 0.84-0.91), suggesting that the smoking-free
legislations might have reduced acute MI occurrence by
13% on average. The study in New York observed an 8%
reduction in hospitalization for acute myocardial infarc-
tion [16]. The authors estimated that the decline would
have been 19% if there had been no prior local smoking
restrictions. When we re-ran the analysis inputting a 19%
reduction rather than 8%, the pooled estimate remained as
87% (95% CI: 83% to 90%).
Figure 1 Forest plot of random effects meta-analysis of studies examining the effect of smoke-free legislation on acute myocardial infarction.
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geneity in the risk estimate in different areas (p<0.001).
The publication bias of the studies was examined by ana-
lyzing the funnel plot and Egger's regression test. As
shown in Figure 2, the funnel plot appeared asymmetrical,
and Egger's regression test suggested significant asym-
metry (bias coefficient=4.05, p=0.0003), indicating either
publication bias or heterogeneity that cannot be simply
explained by a random-effect meta-analysis.
In the sensitivity analysis, we excluded the studies with
acute MI mortality as the outcome, the result estimate
did not change appreciably (RR=0.89, 95% CI: 0.85-0.93).
When we included only the more recent studies for the
same city in the meta-analysis, the effect remained simi-
lar (RR=0.84, 95% CI: 0.84-0.92).
Further meta-regression analysis showed that the het-
erogeneity was partially explained by the study location
and smoking prevalence rate change. In the univariate
meta-regression analysis, study location (US vs. non-US,
p=0.001) and smoking prevalence rate decrease (p=0.028)
were significantly associated with estimated effect size
(Table 1), and they remained significant predictors afteradjustment for other study covariates in the multivariate
analysis. There was a dose gradient that the higher the
smoking prevalence decreases following the implementa-
tion of the smoking-free legislations, the greater the reduc-
tion in acute myocardial infarction occurrence (Figure 3).Discussion
Since 2004, when the first report of a significant drop
in acute MI rate related to the smoking ban in public
and work places was published for the town of Helena,
Montana [28], there has been an increasing number of
demonstrations of this topic in various countries. The
current study provided an up to date meta-analysis of the
existing literatures on the effectiveness of smoking-free
legislation on the risk of acute MI. Similar to the pooled
estimates published in previous meta-analyses [30,31], this
study of 18 studies (44 estimates) indicated a significant re-
duction of acute MI rate after the implementation of smok-
ing bans in public and work places. To our knowledge, our
study was the first to examine the association between the
acute MI reduction and the corresponding smoking
Figure 2 Funnel plot to illustrate possible small study bias among studies examining the effect of smoke-free legislation on acute
myocardial infarction.
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the association of environmental tobacco smoke with acute
MI.
The findings from this meta-analysis indicated that the
smoking-free legislations were associated with a reduced
risk of acute MI in general population. Overall, the risk of
acute MI decreased by 13%, a moderate effect size com-
pared with previous estimates of a 27% decrease by Dinno
[32], an updated 19% reduction by Glantz [30] and 17% by
two other studies [31,33]. However, our estimate was con-
sistent with a 15% drop by one study [33]. And this was
supported by Pechacek and Babb, which estimated 18% to
19% as the maximum impact that could be expected to be
associated with smoking ban [34]. Some studies reported
separate estimates for different subpopulations, only those
with significant reductions were included by previous
meta-analyses, which might be one reason for the relatively
higher estimate by previous meta-analyses.Table 1 Random effects meta-regression analysis of studies e
myocardial infarction
Variable Univariate model
Coefficient (95% CI) p
Study population
≥500 000
<500 000 0.060(−0.023 to 0.142)
Study location
US
Non-US 0.133(0.057 to 0.209)
Publication Year −0.018(−0.042 to 0.006)
Smoking decrease −0.028(−0.052 to-0.003)We noticed that the results published so far showed a
large variation: studies with smaller population in the
United States [10,11,28,35] usually reported larger reduc-
tions ranging from 27% to 40%, while larger studies usu-
ally reported relative modest reductions: 5% in New
Zealand [36], 8% in New York [16], 13% in four Italian re-
gions [14], and 13% in Switzerland [12]. At the same time,
some subgroup estimates did not find significant reduc-
tion (for example, among people aged 60 years old and
above in Piemont, Italy [15], population aged 30–54 years
old in Christchurch, New Zealand [36]). The discrepancy
among these studies could in part be attributable to differ-
ent compliance with the legislation and different changes
in smoking behavior among different countries.
Our meta-regression analysis showed that the reduction
in acute MI risk was greater in studies with higher smok-
ing prevalence rate decreases, suggesting that the protect-
ive effect of legislation could be directly attributed to thexamining the effect of smoke-free legislation on acute
Multivariate model
value Coefficient (95% CI) p value
0.157 0.048(−0.022 to 0.118) 0.176
0.001 0.124(0.049 to 0.199) 0.001
0.134 −0.005(−0.028 to 0.018) 0.683
0.028 −0.027(−0.049 to −0.006) 0.014
Figure 3 Relationship of AMI decrease with smoking prevalence rate decrease.
Lin et al. BMC Public Health 2013, 13:529 Page 5 of 7
http://www.biomedcentral.com/1471-2458/13/529corresponding smoking rate decrease. This was corrobo-
rated by the study in Arizona, US, which demonstrated a
3.9% decrease in smoking prevalence, inducing a 13%
reduction of acute MI hospitalization [7].
There were several possible pathways linking the smoking
ban regulations to acute MI reduction. The smoking-free
policy could reduce the amount of cigarette consumption
among the active smokers, encourage smoking quitting, en-
hance the awareness of the public about the harmfulness of
smoking, and more importantly reduce environmental to-
bacco smoke exposure among the passive smokers. Thus,
the beneficial effects could be expected to be in a long-run
fashion, besides the short-term effects [37].
The implementation of smoking ban law had been
reported to result in significant decline in environmental
tobacco smoke [16,38]. For example, in New York, after
the implementation of the statewide smoking restriction
law, population exposure to environmental tobacco smoke
declined by nearly 50% and cotinine levels in the saliva
from New York State adults declined from 0.078 ng/ml to
0.041 ng/ml [11,16]. In UK and Ireland, a 95% reduction
in ETS among the general population was reported
9 months after the smoking ban [39]. In Scotland, the in-
door fine particulate matter (PM2.5) concentration de-
clined by 86% two weeks after the Scottish legislation [38].
In Ireland, salivary cotinine concentration among hotel
workers fallen by 69% and air nicotine concentration
dropped by 83% [40].
This finding strengthened our knowledge that passive
smoking was a serious risk factor for acute myocardial
infarction and that its elimination reduced the acute MI
occurrence [41,42]. One percentage decrease in smoking
prevalence was estimated to reduce 2.8 percentage ofacute MI rate on average. And this association was bio-
logically possible. Exposure to ETS could rapidly induce
platelet aggregation, thrombosis, endothelial dysfunction
and inflammation, and these effects were comparable to
those suffered by active smokers [41,42]. These effects
were estimated to increase the risk of acute myocardial
infarction by around 10% globally [43], which was in line
with the current estimate. As this risk factor was rela-
tively easily modifiable, the expansion of the smoke-ban
policy in public and working places were expected to
have a pivotal public health significance.
The strength of the present study included the up to date
pooled estimation of the relationship of acute MI risk with
the smoke-free legislations and the examination of the cor-
relation of this reduction with the corresponding smoking
rate decreases. Meanwhile, a few limitations of this study
should be noted. All the included studies were the eco-
logical studies in study design nature, which caused uncer-
tainty in causal inference. Nonetheless, when taken in
aggregate, these studies offered evidence that smoking bans
were followed by significant reduction in the rate of acute
MI in the general population. A recent study reported
contradicting results on the impact of smoking ban on
acute MI in 387 US counties when adjusting for non-linear
secular trend in acute MI compared with the model
adjusting for linear secular trend [8]. However, most of the
studies included in this meta-analysis did not consider
non-linear trend of acute MI rate [44], which might have
caused concern in our estimate. Future studies should con-
sider the non-linear secular trend in acute MI occurrence.
Temporal trend of acute MI rate might be influenced by
factors other than smoking exposure, such as long-term
trend, other air pollutants, atmospheric temperature,
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and preventive strategies, which were not taken into ac-
count in this meta-analysis. It was also possible that the
reduction in acute MI risk could be due to the reduced
amount of cigarettes smoked. It should also be noted
that the smoking rate used in the analysis came from di-
verse sources, where the definition of smoking might be
different, however, we used the difference of smoking
prevalence before and after the smoking free legislation
as the indicator, so this should not have influenced the
result seriously.
Conclusion
The present meta-analysis of 18 individual studies with 44
estimates suggests that smoking bans are associated with
significant reduction in AMI occurrence, and that this
reduction might be partly due to the declines in smoking
prevalence following the smoke-free legislations. Health
policy makers, health care professionals should strongly
advocate more comprehensive smoking restrictions in
public areas and workplaces.Statement
The study adheres to the PRISMA guidelines for system-
atic reviews.
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